A MIF haplotype is associated with the outcome of patients with severe sepsis: A case control study

Journal of Translational Medicine

Volumn 7, Issue , 2009, Pages

  Lehmann, Lutz E ^a   Book, Malte ^a   Hartmann, Wolfgang ^b   Weber, Stefan U ^b   Schewe, Jens Christian ^b   Klaschik, Sven ^b   Hoeft, Andreas ^b   Stüber, Frank ^a  

^a UNIVERSITY OF BERN   (Switzerland)

^b UNIVERSITY OF BONN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

MACROPHAGE MIGRATION INHIBITION FACTOR;

ADULT; ARTICLE; CASE CONTROL STUDY; CAUCASIAN; CONTROLLED STUDY; DISEASE PREDISPOSITION; DISEASE SEVERITY; FEMALE; GENE ACTIVITY; GENE FREQUENCY; GENE FUNCTION; GENE LOCATION; GENOTYPE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PROMOTER REGION; REAL TIME POLYMERASE CHAIN REACTION; REGULATORY MECHANISM; SEPSIS; SEQUENCE ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM; ADOLESCENT; GENETIC PREDISPOSITION; GENETICS; MIDDLE AGED; MORTALITY;

ADOLESCENT; ADULT; CASE-CONTROL STUDIES; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HAPLOTYPES; HUMANS; MACROPHAGE MIGRATION-INHIBITORY FACTORS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; SEPSIS; YOUNG ADULT;

EID: 71949087570     PISSN: None     EISSN: 14795876     Source Type: Journal    
DOI: 10.1186/1479-5876-7-100     Document Type: Article

References (43)

1. Baugh JA, Bucala R. Macrophage migration inhibitory factor. Crit Care Med 2002, 30:S27-S35.
2. Calandra T, Roger T. Macrophage migration inhibitory factor: a regulator of innate immunity. Nat Rev Immunol 2003, 3:791-800. 10.1038/nri1200, 14502271.
3. David JR. Delayed hypersensitivity in vitro: its mediation by cell-free substances formed by lymphoid cell-antigen interaction. Proc Natl Acad Sci USA 1966, 56:72-77. 10.1073/pnas.56.1.72, 285677, 5229858.
4. Bacher M, Metz CN, Calandra T, Mayer K, Chesney J, Lohoff M, Gemsa D, Donnelly T, Bucala R. An essential regulatory role for macrophage migration inhibitory factor in T-cell activation. Proc Natl Acad Sci USA 1996, 93:7849-7854. 10.1073/pnas.93.15.7849, 38837, 8755565.
5. Bernhagen J, Calandra T, Mitchell RA, Martin SB, Tracey KJ, Voelter W, Manogue KR, Cerami A, Bucala R. MIF is a pituitary-derived cytokine that potentiates lethal endotoxaemia. Nature 1993, 365:756-759. 10.1038/365756a0, 8413654.
6. Calandra T, Bernhagen J, Mitchell RA, Bucala R. The macrophage is an important and previously unrecognized source of macrophage migration inhibitory factor. J Exp Med 1994, 179:1895-1902. 10.1084/jem.179.6.1895, 2191507, 8195715.
7. Nishihira J, Koyama Y, Mizue Y. Identification of macrophage migration inhibitory factor (MIF) in human vascular endothelial cells and its induction by lipopolysaccharide. Cytokine 1998, 10:199-205. 10.1006/cyto.1997.0276, 9576065.
8. Calandra T, Bernhagen J, Metz CN, Spiegel LA, Bacher M, Donnelly T, Cerami A, Bucala R. MIF as a glucocorticoid-induced modulator of cytokine production. Nature 1995, 377:68-71. 10.1038/377068a0, 7659164.
9. Roger T, David J, Glauser MP, Calandra T. MIF regulates innate immune responses through modulation of Toll-like receptor 4. Nature 2001, 414:920-924. 10.1038/414920a, 11780066.
10. Kleemann R, Hausser A, Geiger G, Mischke R, Burger-Kentischer A, Flieger O, Johannes FJ, Roger T, Calandra T, Kapurniotu A, Grell M, Finkelmeier D, Brunner H, Bernhagen J. Intracellular action of the cytokine MIF to modulate AP-1 activity and the cell cycle through Jab1. Nature 2000, 408:211-216. 10.1038/35041591, 11089976.
11. Roger T, Glauser MP, Calandra T. Macrophage migration inhibitory factor (MIF) modulates innate immune responses induced by endotoxin and Gram-negative bacteria. J Endotoxin Res 2001, 7:456-460.
12. Emonts M, Sweep FC, Grebenchtchikov N, Geurts-Moespot A, Knaup M, Chanson AL, Erard V, Renner P, Hermans PW, Hazelzet JA, Calandra T. Association between high levels of blood macrophage migration inhibitory factor, inappropriate adrenal response, and early death in patients with severe sepsis. Clin Infect Dis 2007, 44:1321-1328. 10.1086/514344, 17443469.
13. Chuang CC, Wang ST, Chen WC, Chen CC, Hor LI, Chuang AY. Increases in serum macrophage migration inhibitory factor in patients with severe sepsis predict early mortality. Shock 2007, 27:503-506. 10.1097/SHK.0b013e31802c024b, 17438455.
14. Donn RP, Shelley E, Ollier WE, Thomson W. A novel 5'-flanking region polymorphism of macrophage migration inhibitory factor is associated with systemic-onset juvenile idiopathic arthritis. Arthritis Rheum 2001, 44:1782-1785. 10.1002/1529-0131(200108)44:8<1782::AID-ART314>3.0.CO;2-#, 11508429.
15. Baugh JA, Chitnis S, Donnelly SC, Monteiro J, Lin X, Plant BJ, Wolfe F, Gregersen PK, Bucala R. A functional promoter polymorphism in the macrophage migration inhibitory factor (MIF) gene associated with disease severity in rheumatoid arthritis. Genes Immun 2002, 3:170-176. 10.1038/sj.gene.6363867, 12070782.
16. Donn R, Alourfi Z, De BF, Meazza C, Zeggini E, Lunt M, Stevens A, Shelley E, Lamb R, Ollier WE, Thomson W, Ray D. Mutation screening of the macrophage migration inhibitory factor gene: positive association of a functional polymorphism of macrophage migration inhibitory factor with juvenile idiopathic arthritis. Arthritis Rheum 2002, 46:2402-2409. 10.1002/art.10492, 12355488.
17. Radstake TR, Sweep FC, Welsing P, Franke B, Vermeulen SH, Geurts-Moespot A, Calandra T, Donn R, van Riel PL. Correlation of rheumatoid arthritis severity with the genetic functional variants and circulating levels of macrophage migration inhibitory factor. Arthritis Rheum 2005, 52:3020-3029. 10.1002/art.21285, 16200611.
18. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 1992, 20:864-874.
19. Vincent JL, Moreno R, Takala J, Willatts S, De MA, Bruining H, Reinhart CK, Suter PM, Thijs LG. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med 1996, 22:707-710. 10.1007/BF01709751, 8844239.
20. Dellinger RP, Carlet JM, Masur H, Gerlach H, Calandra T, Cohen J, Gea-Banacloche J, Keh D, Marshall JC, Parker MM, Ramsay G, Zimmerman JL, Vincent JL, Levy MM. Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock. Intensive Care Med 2004, 30:536-555. 10.1007/s00134-004-2398-y, 14997291.
21. Amoli MM, Donn RP, Thomson W, Hajeer AH, Garcia-Porrua C, Lueiro M, Ollier WE, Gonzalez-Gay MA. Macrophage migration inhibitory factor gene polymorphism is associated with sarcoidosis in biopsy proven erythema nodosum. J Rheumatol 2002, 29:1671-1673.
22. Temple SE, Cheong KY, Price P, Waterer GW. The microsatellite, macrophage migration inhibitory factor -794, may influence gene expression in human mononuclear cells stimulated with E. coli or S. pneumoniae. Int J Immunogenet 2008, 35:309-316. 10.1111/j.1744-313X.2008.00781.x, 18680514.
23. Lehmann LE, Novender U, Schroeder S, Pietsch T, von ST, Putensen C, Hoeft A, Stuber F. Plasma levels of macrophage migration inhibitory factor are elevated in patients with severe sepsis. Intensive Care Med 2001, 27:1412-1415. 10.1007/s001340000782, 11511957.
24. Martinez A, Orozco G, Varade J, Sanchez LM, Pascual D, Balsa A, Garcia A, de la Concha EG, Fernandez-Gutierrez B, Martin J, Urcelay E. Macrophage migration inhibitory factor gene: influence on rheumatoid arthritis susceptibility. Hum Immunol 2007, 68:744-747. 10.1016/j.humimm.2007.06.007, 17869648.
25. Oliver J, Marquez A, Gomez-Garcia M, Martinez A, Mendoza JL, Vilchez JR, Lopez-Nevot MA, Pinero A, de la Concha EG, Nieto A, Urcelay E, Martin J. Association of the macrophage migration inhibitory factor gene polymorphisms with inflammatory bowel disease. Gut 2007, 56:150-151. 10.1136/gut.2006.107649, 17172590.
26. Nohara H, Okayama N, Inoue N, Koike Y, Fujimura K, Suehiro Y, Hamanaka Y, Higaki S, Yanai H, Yoshida T, Hibi T, Okita K, Hinoda Y. Association of the -173 G/C polymorphism of the macrophage migration inhibitory factor gene with ulcerative colitis. J Gastroenterol 2004, 39:242-246. 10.1007/s00535-003-1284-7, 15065001.
27. Fei BY, Lv HX, Yang JM, Ye ZY. Association of MIF-173 gene polymorphism with inflammatory bowel disease in Chinese Han population. Cytokine 2008, 41:44-47. 10.1016/j.cyto.2007.10.010, 18054247.
28. Hizawa N, Yamaguchi E, Takahashi D, Nishihira J, Nishimura M. Functional polymorphisms in the promoter region of macrophage migration inhibitory factor and atopy. Am J Respir Crit Care Med 2004, 169:1014-1018. 10.1164/rccm.200307-933OC, 14962818.
29. Mizue Y, Ghani S, Leng L, McDonald C, Kong P, Baugh J, Lane SJ, Craft J, Nishihira J, Donnelly SC, Zhu Z, Bucala R. Role for macrophage migration inhibitory factor in asthma. Proc Natl Acad Sci USA 2005, 102:14410-14415. 10.1073/pnas.0507189102, 1242335, 16186482.
30. Wu SP, Leng L, Feng Z, Liu N, Zhao H, McDonald C, Lee A, Arnett FC, Gregersen PK, Mayes MD, Bucala R. Macrophage migration inhibitory factor promoter polymorphisms and the clinical expression of scleroderma. Arthritis Rheum 2006, 54:3661-3669. 10.1002/art.22179, 17075815.
31. Sanchez E, Gomez LM, Lopez-Nevot MA, Gonzalez-Gay MA, Sabio JM, Ortego-Centeno N, de RE, Anaya JM, Gonzalez-Escribano MF, Koeleman BP, Martin J. Evidence of association of macrophage migration inhibitory factor gene polymorphisms with systemic lupus erythematosus. Genes Immun 2006, 7:433-436. 10.1038/sj.gene.6364310, 16724072.
32. Donn RP, Plant D, Jury F, Richards HL, Worthington J, Ray DW, Griffiths CE. Macrophage migration inhibitory factor gene polymorphism is associated with psoriasis. J Invest Dermatol 2004, 123:484-487. 10.1111/j.0022-202X.2004.23314.x, 15304087.
33. Yende S, Angus DC, Kong L, Kellum JA, Weissfeld L, Ferrell R, Finegold D, Carter M, Leng L, Peng ZY, Bucala R. The influence of macrophage migration inhibitory factor gene polymorphisms on outcome from community-acquired pneumonia. FASEB J 2009, 23:2403-2411. 10.1096/fj.09-129445, 19346297.
34. Gomez LM, Sanchez E, Ruiz-Narvaez EA, Lopez-Nevot MA, Anaya JM, Martin J. Macrophage migration inhibitory factor gene influences the risk of developing tuberculosis in northwestern Colombian population. Tissue Antigens 2007, 70:28-33. 10.1111/j.1399-0039.2007.00843.x, 17559578.
35. Awandare GA, Martinson JJ, Were T, Ouma C, Davenport GC, Ong'echa JM, Wang W, Leng L, Ferrell RE, Bucala R, Perkins DJ. MIF (macrophage migration inhibitory factor) promoter polymorphisms and susceptibility to severe malarial anemia. J Infect Dis 2009, 200:629-637. 10.1086/600894, 19591577.
36. Dhanantwari P, Nadaraj S, Kenessey A, Chowdhury D, Al-Abed Y, Miller EJ, Ojamaa K. Macrophage migration inhibitory factor induces cardiomyocyte apoptosis. Biochem Biophys Res Commun 2008, 371:298-303. 10.1016/j.bbrc.2008.04.070, 18439909.
37. Bozza FA, Gomes RN, Japiassu AM, Soares M, Castro-Faria-Neto HC, Bozza PT, Bozza MT. Macrophage migration inhibitory factor levels correlate with fatal outcome in sepsis. Shock 2004, 22:309-313. 10.1097/01.shk.0000140305.01641.c8, 15377884.
38. Gao L, Flores C, Fan-Ma S, Miller EJ, Moitra J, Moreno L, Wadgaonkar R, Simon B, Brower R, Sevransky J, Tuder RM, Maloney JP, Moss M, Shanholtz C, Yates CR, Meduri GU, Ye SQ, Barnes KC, Garcia JG. Macrophage migration inhibitory factor in acute lung injury: expression, biomarker, and associations. Transl Res 2007, 150:18-29. 10.1016/j.trsl.2007.02.007, 1989118, 17585860.
39. Shalhub S, Junker CE, Imahara SD, Mindrinos MN, Dissanaike S, O'Keefe GE. Variation in the TLR4 gene influences the risk of organ failure and shock posttrauma: a cohort study. J Trauma 2009, 66:115-122. 10.1097/TA.0b013e3181938d50, 19131814.
40. Sipahi T, Kuybulu A, Ozturk A, Akar N. Protein Z G79A Polymorphism in Patients With Severe Sepsis. Clin Appl Thromb Hemost 2009, , http://cat.sagepub.com/cgi/content/abstract/1076029608330010v1
41. Russell JA, Wellman H, Walley KR. Protein C rs2069912 C allele is associated with increased mortality from severe sepsis in North Americans of East Asian ancestry. Hum Genet 2008, 123:661-663. 10.1007/s00439-008-0509-5, 18496716.
42. Henckaerts L, Nielsen KR, Steffensen R, Van SK, Mathieu C, Giulietti A, Wouters PJ, Milants I, Vanhorebeek I, Langouche L, Vermeire S, Rutgeerts P, Thiel S, Wilmer A, Hansen TK, Van den BG. Polymorphisms in innate immunity genes predispose to bacteremia and death in the medical intensive care unit. Crit Care Med 2009, 37:192-193. 10.1097/CCM.0b013e31819263d8, 19050632.
43. Read RC, Teare DM, Pridmore AC, Naylor SC, Timms JM, Kaczmarski EB, Borrow R, Wilson AG. The tumor necrosis factor polymorphism TNF (-308) is associated with susceptibility to meningococcal sepsis, but not with lethality. Crit Care Med 2009, 37:1237-1243. 10.1097/CCM.0b013e31819c39bc, 19242354.